相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeted agents in non-small cell lung cancer (NSCLC): Clinical developments and rationale for the combination with thoracic radiotherapy
Pek Keng Koh et al.
CANCER TREATMENT REVIEWS (2012)
Combining angiogenesis inhibition and radiotherapy: A double-edged sword
Esther A. Kleibeuker et al.
DRUG RESISTANCE UPDATES (2012)
Cancer-Stimulated Mesenchymal Stem Cells Create a Carcinoma Stem Cell Niche via Prostaglandin E2 Signaling
Hua-Jung Li et al.
CANCER DISCOVERY (2012)
Cytosolic phospholipase A2 as a mediator of disease pathogenesis
Amanda Linkous et al.
CELLULAR MICROBIOLOGY (2010)
Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis
Amanda G. Linkous et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo
Honglu Zhang et al.
CANCER RESEARCH (2009)
Cytosolic Phospholipase A2: Targeting Cancer through the Tumor Vasculature
Amanda Linkous et al.
CLINICAL CANCER RESEARCH (2009)
Activation of Cytosolic Phospholipase A2-α as a Novel Mechanism Regulating Endothelial Cell Cycle Progression and Angiogenesis
Shane P. Herbert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Anastellin, the Angiostatic Fibronectin Peptide, Is a Selective Inhibitor of Lysophospholipid Signaling
Anthony Ambesi et al.
MOLECULAR CANCER RESEARCH (2009)
Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium
E. M. Yazlovitskaya et al.
CELL DEATH AND DIFFERENTIATION (2008)
Mechanism of radiation-induced bystander effects: a unifying model
Tom K. Hei et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
The confluence-dependent interaction of cytosolic phospholipase A2-α with annexin A1 regulates endothelial cell prostaglandin E2 generation
Shane P. Herbert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Radiation-induced cell signaling: inside-out and outside-in
Kristoffer Valerie et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Roles of cPLA2α and arachidonic acid in cancer
Masako Nakanishi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
Transactivation of fetal liver kinase-1/kinase-insert domain-econtaining receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation
Y Fujita et al.
ENDOCRINOLOGY (2006)
Inhibitors of brain phospholipase A(2) activity: Their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders
Akhlaq A. Farooqui et al.
PHARMACOLOGICAL REVIEWS (2006)
Cytosolic phospholipase A2-α and cyclooxygenase-2 localize to intracellular membranes of EA.hy.926 endothelial cells that are distinct from the endoplasmic reticulum and the Golgi apparatus
S Grewal et al.
FEBS JOURNAL (2005)
Phospholipase A2 isoforms:: a perspective
S Chakraborti
CELLULAR SIGNALLING (2003)
Tumor response to radiotherapy regulated by endothelial cell apoptosis
M Garcia-Barros et al.
SCIENCE (2003)
The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001 - Summary and conclusions
U Ringborg et al.
ACTA ONCOLOGICA (2003)
Delayed oxidant-induced cell death involves activation of phospholipase A2
M Zhao et al.
FEBS LETTERS (2001)
Induction of cPLA2 in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-jun
SA Blaine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Differential role of cytosolic phospholipase A2 in the invasion of brain microvascular endothelial cells by Escherichia coli and Listeria monocytogenes
A Das et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Postoperative adjuvant therapy for patients with resected non-small cell lung cancer: still controversial after all these years
H Wagner
CHEST (2000)
分享论文
